Regeneron, Adicet Partner to Develop Immune Cell Therapeutics for Certain Cancers
News
Regeneron Pharmaceuticals and Adicet Bio have announced a new strategic collaboration and licensing agreement to develop next-generation immune cell therapeutics in several hematological and solid tumors. The two partners will develop immune ... Read more